QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Henagliflozin, a Novel Selective Inhibitor of Sodium-Glucose Cotransporter 2, in Healthy Subjects Following Single- and Multiple-dose Administration 期刊论文 CLINICAL THERAPEUTICS, 2021, 卷号: 43, 期号: 2, 页码: 396-409 作者:  Zhang, Yi-fan;  Liu, Yan-mei;  Yu, Chen;  Wang, Ya-ting;  Zhan, Yan 收藏  |  浏览/下载：68/0  |  提交时间：2021/05/24 diabetes  henagliflozin  pharmacodynamics  pharmacokinetics  SGLT-2 inhibitors   A phase I study of AST1306, a novel irreversible EGFR and HER2 kinase inhibitor, in patients with advanced solid tumors 期刊论文 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 卷号: 7 作者:  Zhang, Jian;  Cao, Junning;  Li, Jin;  Zhang, Yifan;  Chen, Zhiyu 收藏  |  浏览/下载：18/0  |  提交时间：2019/01/08 AST1306  ErbB family  Irreversible tyrosine kinase inhibitor  Phase I   Assessment of chlorpyrifos exposure and absorbed daily doses among infants living in an agricultural area of the Province of Jiangsu, China 期刊论文 INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 2014, 卷号: 87, 期号: 7 作者:  Liu, Ping;  Wu, Chun-hua;  Chang, Xiu-li;  Qi, Xiao-juan;  Zheng, Ming-lan 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/19 Urinary metabolites  Biomonitoring  Absorbed daily dose  3,5,6-Trichloro-2-pyridinol  Infants